Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
MCT6.0
MCT Oil – Forschung
Überwiegend Mechanismus / Beobachtung
127 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu MCT Oil sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 1983–2026 mit einer typischen Studiengröße von 70 Teilnehmenden.
Basierend auf 127 Studien · 15 Meta-Analysen · 99 RCTs · 4,791 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
2geholfen· 125 weitere ohne bewertete Effektdaten
Nach Outcome
Weight management
Überwiegend Mechanismus / Beobachtung96 Studien
Cholesterol & lipids
Überwiegend Mechanismus / Beobachtung70 Studien
Cognitive function
Überwiegend Mechanismus / Beobachtung34 Studien
Therapeutic & clinical
Überwiegend Mechanismus / Beobachtung19 Studien
Endurance & exercise performanceSchnelle Ketonkörperproduktion liefert alternativen Brennstoff während des Trainings · 30-60 Minuten
Überwiegend Mechanismus / Beobachtung5 Studien
Glucose & metabolicErhöht die Ketonverfügbarkeit und unterstützt die metabolische Flexibilität · 1-4 Wochen
Überwiegend Mechanismus / Beobachtung3 Studien
Digestive health
Zu wenige bewertete Studien2 Studien
Safety profile
Zu wenige bewertete Studien2 Studien
Heart & blood pressure
Zu wenige bewertete Studien1 Studie
Energy & fatigueSchnelle, anhaltende Energie durch Ketonproduktion · 30-60 Minuten
Zu wenige bewertete Studien1 Studie
Inflammation
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 16 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
50%
über Studien hinweg
Untersuchte Personen
4,791
typische Studie: 70 Personen
Stärkste Designs
114
15 gepoolt, 99 randomisiert
Zeigte Nutzen
100%
2/2 Studien
Wie lange Studien liefen
1–4 Wochen
1
1–3 Monate
2
3+ Monate
2
Untersuchte Populationen
People with neurodegenerative disease1
Adults with disease1
General population1
Parkinson's disease patients1
Aktives Forschungsgebiet
51 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
198320042026
1Neurodegenerative disease managementSystematische Übersichtn=979 · large study2021
Einfach gesagt: Overall, 3/17 studies carried a low risk of bias.
Dewsbury LS et al. · Advances in nutrition (Bethesda, Md.) (2021)
Overall, 3/17 studies carried a low risk of bias.
Based on available evidence, exogenous ketogenic agents may be more feasible than dietary interventions in NDD from a compliance and adherence perspective; more research is required to confirm this.
3Clinical benefits of exogenous ketosisSystematische Übersicht2025
Einfach gesagt: Exogenous ketosis shows potential in neurological, metabolic, and cardiovascular disorders, while evidence in psychiatric and inflammatory conditions remains scarce and preliminary.
Mohib O et al. · Nutrients (2025)
Exogenous ketosis shows potential in neurological, metabolic, and cardiovascular disorders, while evidence in psychiatric and inflammatory conditions remains scarce and preliminary.
Ketone esters appear preferable for effective and tolerable ketosis.
Future research should focus on identifying responsive patient populations, optimizing treatment regimens, and conducting long-term clinical trials with hard endpoints to validate these findings.
Einfach gesagt: Limitations include heterogeneous intervention conditions, such as different types of dispersions, caffeine intake, limited number of studies and variability in study design.
Frenser M et al. · Nutrients (2024)
Forest plot analysis showed heterogeneous data.
The data suggest a non-linear relationship between C8, carbohydrate intake and ketone production.
Further studies are needed to investigate the influence of different carbohydrates on C8-induced ketogenesis.
Einfach gesagt: In this meta-analysis, we demonstrated that MCTs can induce mild ketosis and may improve cognition in patients with mild cognitive impairment and Alzheimer's disease.
Avgerinos KI et al. · Ageing research reviews (2020)
In this meta-analysis, we demonstrated that MCTs can induce mild ketosis and may improve cognition in patients with mild cognitive impairment and Alzheimer's disease.
However, risk of bias of existing studies necessitates future trials.
Einfach gesagt: Although animal studies indicate promising results, research on the effect of ketogenic therapy in PD is still in its infancy, with RCTs conducted on humans being heterogeneous and lacking PD-specific outcomes.
Grammatikopoulou MG et al. · Maturitas (2022)
Although animal studies indicate promising results, research on the effect of ketogenic therapy in PD is still in its infancy, with RCTs conducted on humans being heterogeneous and lacking PD-specific outcomes.
More studies are required to recommend or refute the use of ketogenic therapy in PD.
Einfach gesagt: These findings indicate that the magnitude of the increase in DIT is influenced by the energy intake, macronutrient composition, and eating pattern of the meal.
Quatela A et al. · Nutrients (2016)
Meals with medium chain triglycerides had a significantly higher DIT than long chain triglycerides (meta-analysis, p = 0.002).
Consuming the same meal as a single bolus eating event compared to multiple small meals or snacks was associated with a significantly higher DIT (meta-analysis, p = 0.02).
Unclear or inconsistent findings were found by comparing the consumption of meals quickly or slowly, and palatability was not significantly associated with DIT.
Einfach gesagt: Therefore, further studies are necessary to explore the long-term effects and challenges of the KDT programs in Latin America.
Shibaki R, de Oliveira Franco MDNS, Camargo JSL, Citro GM, Ramos EM, Bruzzone M. · Epilepsy research (2026)
Meta-analysis results indicate that 69% of patients (95% IC: 57-82%) experienced seizure reduction during KDT treatment.
Additionally, In terms of seizure freedom, the analysis exhibits a pooled effect of 12% of patients (95% CI: 9-16%) that achieved complete seizure freedom.
Adverse effects were analyzed as secondary outcomes, with 270 patients experiencing treatment related side effects.